Authorized Share Capital. Immediately prior to the Closing, the authorized share capital of the Company consists of the following: (i) A total of 4,282,500 authorized ordinary shares, par value US$0.01 per share, of the Company (the “Ordinary Shares”), of which 1,150,000 shares are issued and outstanding, and (ii) 717,500 Series A Shares, none of which are outstanding.
Appears in 2 contracts
Samples: Preferred Share Purchase Agreement, Series a Preferred Share Purchase Agreement (VanceInfo Technologies Inc.)
Authorized Share Capital. Immediately prior to the Closing, the The authorized share capital of the Company consists of the following: (i) A total of 4,282,500 authorized 1,000,000,000 ordinary shares, par value US$NIS 0.01 per ordinary share, of the Company (the “Ordinary Shares”), of which 1,150,000 72,399,932 ordinary shares are issued and outstanding, and (ii) 717,500 Series A Shares, none of which are outstanding.
Appears in 1 contract
Samples: Convertible Bridge Loan Agreement (Todos Medical Ltd.)
Authorized Share Capital. Immediately prior to As of the Closingdate hereof, the authorized share capital of the Company consists of the following: (iA) A total of 4,282,500 authorized ordinary shares, par value US$0.01 per share320,000,000 Ordinary Shares, of the Company which, 90,554,115 are issued and outstanding and (the “Ordinary B) 4,000,000 High Voting Shares”), of which 1,150,000 shares 3,000,000 are issued and outstanding, and (ii) 717,500 Series A Shares, none of which are outstanding.
Appears in 1 contract
